로딩 중…
지수 로딩 중…
RP Bio Inc.
314140· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩5,200-5.45%
2026-06-19
Price Chart
RP Bio Inc.-9.57%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 45.07B KRW |
| Revenue | 137.35B KRW |
| Net Income | 5.60B KRW |
| Total Assets | 164.69B KRW |
| Net Assets | 109.32B KRW |
| Employees | 493 |
| Value | |
| P/E | 8.04x |
| P/B | 0.41x |
| PEG | 0.15x |
| P/S | 0.33x |
| EV/EBITDA | 8.38x |
| FCF Yield | 12.87% |
| Profitability | |
| ROE | 5.12% |
| ROA | 3.40% |
| Op. Margin | 4.15% |
| Revenue Growth | 3.34% |
| Earnings Growth | 54.27% |
| Financial Health | |
| Debt Ratio | 150.64% |
| Total Debt | 16.00B KRW |
| FCF | 5.80B KRW |
| Cash | 13.25B KRW |
| Current Ratio | 1.34x |
| Net Debt/EBITDA | 0.48x |
| Dividend | |
| Div. Yield | 0.91% |
| Performance | |
| 1Y Return | -9.57% |
| 1M Return | -11.86% |
| From 52W High | -43.04% |
| 1Y MDD | -36.83% |
| Trading | |
| Volume | 12,089 shares |
| Foreign Own. | 1.98% |
| Per Share | |
| EPS | 646 KRW |
| BPS | 12,639 KRW |
Company Info
RP Bio, established in 2016 through a spin-off and listed on KOSDAQ in 2022, is the sole domestic company inheriting Dr. RP Scherer's soft capsule manufacturing technology since 1983. The company manufactures and supplies various pharmaceuticals and health functional foods, including soft capsules, holding over 60% of the domestic soft capsule market share. RP Bio maintains long-term collaborations with major pharmaceutical companies, possesses 28 patents, and pursues global market expansion strategies based on its quality competitiveness.